The Latest Breaking News from TransMedics Group

TransMedics Group shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

TransMedics Group and two other mid-cap names just posted dominant performances in Q1, smashing forecasts set by Wall Street analysts.

TransMedics Group sees its Relative Strength Rating move into the 80-plus level.

TransMedics Group shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Morning Markets The S&P 500 Index ( $SPX ) ( SPY ) is up +0.28%, the Dow Jones Industrials Index ( $DOWI ) ( DIA ) up +0.21%, and the Nasdaq 100 Index ( $IUXX ) ( QQQ ) is up +0.77%. Stocks this morning are higher. This is despite...

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.16%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.04%. Stock index futures this morning are mixed after comments Monday night from Minneapolis Fed President Kashkari dampened hopes that the Fed was done raising interest rates. Also,...

Gainers

Upgrades

TransMedics Group (NASDAQ:TMDX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings TransMedics Group reported in-line EPS of $-0.38 versus an estimate of $-0.38.